For the first time, the investigation demonstrated that AF boosted CD8+Ve T-cell tumour infiltration in vivo and modified immunological checkpoint PD-L1 expression in an ERK1/2-MYC-dependent way. The gene discussed is CD8A; the disease is neoplasm.